ELIZAREVA, E.,
YANBAEV, Y.,
REDKINA, N.,
KUDASHKINA, N.,
ELIZARYEV, A.,
KHAMIDULLIN, I. (2019) and transition of heavy metals has been established, which indicates the presence of protective
mechanismsBeylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) and tumor surgery are limited by anticancer drug
resistance and tumor invasion. Evidence suggests
Beilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) exploitation as diagnostic biomarkers. Their covalent closed cyclic structure resulting in
resistance to RNases
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) of multidrug
resistance. The way of overcoming these shortcomings is to create anticancer drugs with improved
RNAs through methylation, a key
mechanism that modulates gene expression. This process, involving the addition
Kudriashov, Valentin,
Sufianov, Albert,
Mashkin, Andrey,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Lyulin, Sergey,
Beylerli, Ozal (2023) and protein, such as adipocyte proliferation and dif-
ferentiation, inflammation, and insulin
resistanceПОТЕНЦИАЛ КОМПЛЕМЕНТАРНОЙ АЛЬТЕРНАТИВНОЙ МЕДИЦИНЫ В БОРЬБЕ С АНТИМИКРОБНОЙ РЕЗИСТЕНТНОСТЬЮTHE POTENTIAL OF COMPLEMENTARY ALTERNATIVE MEDICINE IN THE FIGHT AGAINST ANTIMICROBIAL
RESISTANCE